Activation of the TGF-<i>β</i> Pathway Enhances the Efficacy of Platinum-Based Chemotherapy in Small Cell Lung Cancer Patients

<div>Comparison of immune cell infiltration in SCLC patients. (a) Immune cell infiltration in the Local-SCLC cohort. (b) Immune cell infiltration in the George-SCLC cohort.</div>

Disease Markers

fig5

Figure 5

Figure 5: Activation of the TGF-<i>β</i> Pathway Enhances the Efficacy of Platinum-Based Chemotherapy in Small Cell Lung Cancer Patients 

Disease Markers

Activation of the TGF-β Pathway Enhances the Efficacy of Platinum-Based Chemotherapy in Small Cell Lung Cancer Patients

Figure 5